ID

32475

Beschreibung

Study ID: 106837 Clinical Study ID: HZA106837 Study Title: A Long-Term, Randomized, Double-Blind, Parallel Group Study of Fluticasone Furoate/GW642444 Inhalation Powder Once-Daily and Fluticasone Furoate Inhalation Powder Once-Daily in Subjects with Asthma Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01086384 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: fluticasone furoate/vilanterol Trade Name: Relvar Study Indication: Asthma

Stichworte

  1. 02.11.18 02.11.18 -
  2. 30.11.18 30.11.18 -
Rechteinhaber

GSK group of companies

Hochgeladen am

2. November 2018

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

A Parallel Group Study of Fluticasone Furoate/Vilanterol in Subjects with Asthma - 106837

Initial Serious Adverse Event Form

Randomisation
Beschreibung

Randomisation

Did SAE occur after initiation of study medication?
Beschreibung

Did SAE occur after initiation of study medication?

Datentyp

boolean

SAE Sequence Number
Beschreibung

SAE Sequence Number

Datentyp

integer

Serious Adverse Event Entry
Beschreibung

Serious Adverse Event Entry

Start Date
Beschreibung

Start Date

Datentyp

date

Outcome
Beschreibung

Outcome

Datentyp

text

End Date
Beschreibung

if FATAL, Date of Death

Datentyp

date

Maximum Intensity
Beschreibung

Maximum Intensity

Datentyp

text

Intensity at onset of event
Beschreibung

Intensity at onset of event

Datentyp

text

Maximum Grade
Beschreibung

Maximum Grade

Datentyp

text

Grade at onset of event
Beschreibung

Grade at onset of event

Datentyp

text

Maximum Grade of Intensity
Beschreibung

Record maximum grade or intensity throughout duration of event

Datentyp

text

Grade of Intensity at onset of event
Beschreibung

Record grade of intensity at the onset of the event

Datentyp

text

Action taken with Investigational Product(s) as a result of AE?
Beschreibung

Action taken with Investigational Product(s) as a result of AE?

Datentyp

text

Did the subject withdraw from the study as a result of AE?
Beschreibung

Did the subject withdraw from the study as a result of AE?

Datentyp

boolean

Is there a reasonable possibility that the AE may have been caused by the investigational product?
Beschreibung

Use best judgement at initial entry. May be amended when additional information becomes available.

Datentyp

boolean

Duration of AE if < 24 hours
Beschreibung

HH:MM

Datentyp

text

Time to Onset since last Dose
Beschreibung

Time to Onset since last Dose

Datentyp

time

Was the SAE caused by activities related to study participation other than investigational product (e.g., procedures, blood draws, washout, etc)?
Beschreibung

Was the SAE caused by activities related to study participation other than investigational product (e.g., procedures, blood draws, washout, etc)?

Datentyp

boolean

Was the event serious?
Beschreibung

Was the event serious?

Datentyp

boolean

Related Investigational Product
Beschreibung

Related Investigational Product

Datentyp

text

Seriousness
Beschreibung

Seriousness

Level of seriousness of the event
Beschreibung

Level of seriousness of the event

Datentyp

text

Relevant Concomitant/Treatment Medication
Beschreibung

Relevant Concomitant/Treatment Medication

CM Sequence Number
Beschreibung

Iclude any details of any medication that may help explain the SAE, may have caused the SAE or was used to treat the SAE.

Datentyp

text

Drug Name
Beschreibung

Enter drug name, not description (Generic name preferred. If combination product, enter Trade Name).

Datentyp

text

Modified reported term
Beschreibung

Modified reported term

Datentyp

text

Dose
Beschreibung

Dose

Datentyp

float

Unit
Beschreibung

Unit

Datentyp

text

Frequency
Beschreibung

Frequency

Datentyp

text

Route
Beschreibung

Route

Datentyp

text

Start Date
Beschreibung

Start Date

Datentyp

date

Ongoing?
Beschreibung

Ongoing?

Datentyp

boolean

If NO, specify End Date
Beschreibung

If NO, specify End Date

Datentyp

date

Primary Indication
Beschreibung

Enter a medical diagnosis not description

Datentyp

text

Modified reported term
Beschreibung

Modified reported term

Datentyp

text

Drug Type
Beschreibung

Drug Type

Datentyp

text

Relevant Medical Conditions/Risk Factors
Beschreibung

Relevant Medical Conditions/Risk Factors

MHx Sequence Number
Beschreibung

MHx Sequence Number

Datentyp

text

Specific Condition Name
Beschreibung

Enter a medical diagnosis not description.

Datentyp

text

Modified reported term
Beschreibung

Modified reported term

Datentyp

text

Date of onset
Beschreibung

Date of onset

Datentyp

date

Continuing?
Beschreibung

Continuing?

Datentyp

text

If NO, specify date of last occurrence
Beschreibung

If NO, specify date of last occurrence

Datentyp

date

Relevant Diagnosis Results
Beschreibung

Relevant Diagnosis Results

Lab Sequence Number
Beschreibung

Provide details of any tests or procedures carried out to diagnose the SAE.

Datentyp

text

Test Name
Beschreibung

Test Name

Datentyp

text

Test Date
Beschreibung

Test Date

Datentyp

date

Test Result
Beschreibung

Test Result

Datentyp

text

Test Units
Beschreibung

Test Units

Datentyp

text

Normal Low Range
Beschreibung

Normal Low Range

Datentyp

integer

Normal High Range
Beschreibung

Normal High Range

Datentyp

integer

Relevant diagnostic results not noted above
Beschreibung

Relevant diagnostic results not noted above

Datentyp

text

Rechallenge
Beschreibung

Rechallenge

If the investigational product(s) were stopped temporarily, did the reported event(s) recur after investigational products were restarted?
Beschreibung

If the investigational product(s) were stopped temporarily, did the reported event(s) recur after investigational products were restarted?

Datentyp

text

Investigational Product
Beschreibung

Investigational Product

Study Drug
Beschreibung

Study Drug

Datentyp

text

Start Date
Beschreibung

Start Date

Datentyp

date

Stop Date
Beschreibung

Stop Date

Datentyp

date

Regimen
Beschreibung

Regimen

Datentyp

text

General narrative comments
Beschreibung

General narrative comments

A brief narrative description of SAE
Beschreibung

possible other causes of the event (e.g., lack of efficacy, withdrawal of investigational product, the disease under study or other medical conditions) and details of treatment.

Datentyp

text

Non Clinical
Beschreibung

Non Clinical

Send incomplete SAE data to GSK Safety
Beschreibung

Send incomplete SAE data to GSK Safety

Datentyp

text

Receipt by GSK date
Beschreibung

Receipt by GSK date

Datentyp

date

Was the event serious?
Beschreibung

Was the event serious?

Datentyp

boolean

SAE Sequence number
Beschreibung

SAE Sequence number

Datentyp

text

Version Number
Beschreibung

Version Number

Datentyp

text

Case ID
Beschreibung

Case ID

Datentyp

text

Randomisation Number
Beschreibung

Randomisation Number

Datentyp

text

OCEANS Code
Beschreibung

OCEANS Code

Datentyp

text

Ähnliche Modelle

Initial Serious Adverse Event Form

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Randomisation
Did SAE occur after initiation of study medication?
Item
Did SAE occur after initiation of study medication?
boolean
SAE Sequence Number
Item
SAE Sequence Number
integer
Item Group
Serious Adverse Event Entry
Start Date
Item
Start Date
date
Item
Outcome
text
Code List
Outcome
CL Item
Recovered/Resolved (1)
CL Item
Recovering/Resolving (2)
CL Item
Not recovered/not resolved (3)
CL Item
Recovered/Resolved with sequelae  (4)
CL Item
Fatal (5)
End Date
Item
End Date
date
Item
Maximum Intensity
text
Code List
Maximum Intensity
CL Item
[1] Mild (1)
CL Item
[2] Moderate (2)
CL Item
[3] Severe (3)
CL Item
[x] Not applicable (4)
Item
Intensity at onset of event
text
Code List
Intensity at onset of event
CL Item
[1] Mild (1)
CL Item
[2] Moderate (2)
CL Item
[3] Severe (3)
CL Item
[x] Not applicable (4)
Item
Maximum Grade
text
Code List
Maximum Grade
CL Item
Grade 1 (1)
CL Item
Grade 2 (2)
CL Item
Grade 3 (3)
CL Item
Grade 4 (4)
CL Item
Grade 5 (5)
Item
Grade at onset of event
text
Code List
Grade at onset of event
CL Item
Grade 1 (1)
CL Item
Grade 2 (2)
CL Item
Grade 3 (3)
CL Item
Grade 4 (4)
CL Item
Grade 5 (5)
Item
Maximum Grade of Intensity
text
Code List
Maximum Grade of Intensity
CL Item
Mild or Grade 1 (1)
CL Item
Moderate or Grade 2 (2)
CL Item
Severe or Grade 3 (3)
CL Item
Grade 4 (4)
CL Item
Grade 5 (5)
CL Item
Not applicable (6)
Item
Grade of Intensity at onset of event
text
Code List
Grade of Intensity at onset of event
CL Item
Mild or Grade 1 (1)
CL Item
Moderate or Grade 2 (2)
CL Item
Severe or Grade 3 (3)
CL Item
Grade 4 (4)
CL Item
Grade 5 (5)
CL Item
Not applicable (6)
Item
Action taken with Investigational Product(s) as a result of AE?
text
Code List
Action taken with Investigational Product(s) as a result of AE?
CL Item
Investigational product(s) withdrawn (1)
CL Item
Dose reduced (2)
CL Item
Dose increased (3)
CL Item
Dose not changed (4)
CL Item
Dose interrupted (5)
CL Item
Not applicable (6)
Did the subject withdraw from the study as a result of AE?
Item
Did the subject withdraw from the study as a result of AE?
boolean
Is there a reasonable possibility that the AE may have been caused by the investigational product?
Item
Is there a reasonable possibility that the AE may have been caused by the investigational product?
boolean
Duration of AE if < 24 hours
Item
Duration of AE if < 24 hours
text
Time to Onset since last Dose
Item
Time to Onset since last Dose
time
Was the SAE caused by activities related to study participation other than investigational product (e.g., procedures, blood draws, washout, etc)?
Item
Was the SAE caused by activities related to study participation other than investigational product (e.g., procedures, blood draws, washout, etc)?
boolean
Was the event serious?
Item
Was the event serious?
boolean
Related Investigational Product
Item
Related Investigational Product
text
Item Group
Seriousness
Item
Level of seriousness of the event
text
Code List
Level of seriousness of the event
CL Item
results in death (1)
CL Item
is life threatening (2)
CL Item
requires hospitalisation or prolongation of existing hospitalisation  (3)
CL Item
results in disability/incapacity (4)
CL Item
congenital anomaly/birth defect (5)
CL Item
other, specify within general narrative comment (6)
Item Group
Relevant Concomitant/Treatment Medication
CM Sequence Number
Item
CM Sequence Number
text
Drug Name
Item
Drug Name
text
Modified reported term
Item
Modified reported term
text
Dose
Item
Dose
float
Unit
Item
Unit
text
Frequency
Item
Frequency
text
Route
Item
Route
text
Start Date
Item
Start Date
date
Ongoing?
Item
boolean
If NO, specify End Date
Item
If NO, specify End Date
date
Primary Indication
Item
Primary Indication
text
Modified reported term
Item
Modified reported term
text
Drug Type
Item
Drug Type
text
Item Group
Relevant Medical Conditions/Risk Factors
MHx Sequence Number
Item
MHx Sequence Number
text
Specific Condition Name
Item
Specific Condition Name
text
Modified reported term
Item
Modified reported term
text
Date of onset
Item
Date of onset
date
Item
Continuing?
text
Code List
Continuing?
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
If NO, specify date of last occurrence
Item
If NO, specify date of last occurrence
date
Item Group
Relevant Diagnosis Results
Lab Sequence Number
Item
Lab Sequence Number
text
Test Name
Item
Test Name
text
Test Date
Item
Test Date
date
Test Result
Item
Test Result
text
Test Units
Item
Test Units
text
Normal Low Range
Item
Normal Low Range
integer
Normal High Range
Item
Normal High Range
integer
Relevant diagnostic results not noted above
Item
text
Item Group
Rechallenge
Item
If the investigational product(s) were stopped temporarily, did the reported event(s) recur after investigational products were restarted?
text
Code List
If the investigational product(s) were stopped temporarily, did the reported event(s) recur after investigational products were restarted?
CL Item
No (1)
CL Item
Yes (2)
CL Item
Unknown at this time (3)
CL Item
Not applicable (4)
Item Group
Investigational Product
Item
Study Drug
text
Code List
Study Drug
CL Item
Novel dry powder inhaler (1)
Start Date
Item
Start Date
date
Stop Date
Item
Stop Date
date
Regimen
Item
Regimen
text
Item Group
General narrative comments
A brief narrative description of SAE
Item
A brief narrative description of SAE
text
Item Group
Non Clinical
Send incomplete SAE data to GSK Safety
Item
Send incomplete SAE data to GSK Safety
text
Receipt by GSK date
Item
Receipt by GSK date
date
Was the event serious?
Item
Was the event serious?
boolean
SAE Sequence number
Item
SAE Sequence number
text
Version Number
Item
Version Number
text
Case ID
Item
Case ID
text
Randomisation Number
Item
Randomisation Number
text
OCEANS Code
Item
OCEANS Code
text

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video